These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19654531)

  • 1. Survey of steroid usage patterns during and after low-risk penetrating keratoplasty.
    Price FW; Price DA; Ngakeng V; Price MO
    Cornea; 2009 Sep; 28(8):865-70. PubMed ID: 19654531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes.
    Price MO; Price FW
    Ophthalmology; 2006 Oct; 113(10):1785-90. PubMed ID: 16884779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term topical steroid treatment improves graft survival following normal-risk penetrating keratoplasty.
    Nguyen NX; Seitz B; Martus P; Langenbucher A; Cursiefen C
    Am J Ophthalmol; 2007 Aug; 144(2):318-9. PubMed ID: 17659972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention and treatment of corneal graft rejection: current practice patterns (2004).
    Randleman JB; Stulting RD
    Cornea; 2006 Apr; 25(3):286-90. PubMed ID: 16633028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term topical steroid treatment after penetrating keratoplasty in patients with pseudophakic bullous keratopathy.
    Ross AH; Jones MN; Nguyen DQ; Jaycock PD; Armitage WJ; Cook SD; Kaye SB; Tole DM;
    Ophthalmology; 2009 Dec; 116(12):2369-72. PubMed ID: 19815284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention and treatment of corneal graft rejection: current practice patterns of the Cornea Society (2011).
    Kharod-Dholakia B; Randleman JB; Bromley JG; Stulting RD
    Cornea; 2015 Jun; 34(6):609-14. PubMed ID: 25811719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of short-term versus longterm topical steroid treatment on 'idiopathic' endothelial cell loss after normal-risk penetrating keratoplasty.
    Nguyen NX; Pham HN; Langenbucher A; Cursiefen C; Seitz B
    Acta Ophthalmol Scand; 2007 Mar; 85(2):209-12. PubMed ID: 17305736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome of combined penetrating keratoplasty with scleral-sutured posterior chamber intraocular lens implantation.
    Malta JB; Banitt M; Musch DC; Sugar A; Mian SI; Soong HK
    Cornea; 2009 Aug; 28(7):741-6. PubMed ID: 19574915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats.
    Bourges JL; Lallemand F; Agla E; Besseghir K; Dumont JM; BenEzra D; Gurny R; Behar-Cohen F
    Mol Vis; 2006 Dec; 12():1461-6. PubMed ID: 17167400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term use of topical tacrolimus (FK506) in high-risk penetrating keratoplasty.
    Dhaliwal JS; Mason BF; Kaufman SC
    Cornea; 2008 May; 27(4):488-93. PubMed ID: 18434855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical Tacrolimus as Adjuvant Therapy to Corticosteroids in Acute Endothelial Graft Rejection After Penetrating Keratoplasty: A Randomized Controlled Trial.
    Hashemian MN; Latifi G; Ghaffari R; Ghassemi H; Zarei-Ghanavati M; Mohammadi SF; Yasseri M; Fallah Tafti MR; Tafti ZF
    Cornea; 2018 Mar; 37(3):307-312. PubMed ID: 29215395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cyclosporin A combined with dexamethasone in preventing and treating immune rejection after penetrating keratoplasty].
    Xi XH; Qin B; Jiang DY
    Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):627-30. PubMed ID: 15804077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What DSAEK is going on? An alternative to penetrating keratoplasty for endothelial dysfunction.
    Mau K
    Optometry; 2009 Sep; 80(9):513-23. PubMed ID: 19716079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of oral antiviral therapy with valacyclovir or acyclovir after penetrating keratoplasty for herpetic keratitis.
    Goldblum D; Bachmann C; Tappeiner C; Garweg J; Frueh BE
    Br J Ophthalmol; 2008 Sep; 92(9):1201-5. PubMed ID: 18650215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-year follow-up on the effect of oral acyclovir after penetrating keratoplasty for herpetic keratitis.
    Jansen AF; Rijneveld WJ; Remeijer L; Völker-Dieben HJ; Eggink CA; Geerards AJ; Mulder PG; van Rooij J
    Cornea; 2009 Sep; 28(8):843-5. PubMed ID: 19654536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systematic review of penetrating keratoplasty rejection treated by immunosuppressants].
    Sun YJ; Li AP; Pan ZQ; Luo F; Zou LH
    Zhonghua Yan Ke Za Zhi; 2010 Dec; 46(12):1122-7. PubMed ID: 21211228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical cyclosporine.
    Sinha R; Vishnu S; Sharma N; Vajpayee RB
    Ophthalmology; 2009 Oct; 116(10):2038-38.e1. PubMed ID: 19800526
    [No Abstract]   [Full Text] [Related]  

  • 18. Adjunctive intracameral application of corticosteroids in patients with endothelial immune reactions after penetrating keratoplasty: a pilot study.
    Reinhard T; Sundmacher R
    Transpl Int; 2002 Mar; 15(2-3):81-8. PubMed ID: 11935164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fungal keratitis with intracameral extension following penetrating keratoplasty.
    Gupta G; Feder RS; Lyon AT
    Cornea; 2009 Sep; 28(8):930-2. PubMed ID: 19654519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicted long-term outcome of corneal transplantation.
    Borderie VM; Boëlle PY; Touzeau O; Allouch C; Boutboul S; Laroche L
    Ophthalmology; 2009 Dec; 116(12):2354-60. PubMed ID: 19815285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.